Artemid supports Biotech Dental
The Artemid Senior Loan III fund is providing €20 million in financing that will enable the company to continue its international growth, particularly in the United States where the company has just acquired IDS, the last major independent distributor of dental implants.
Biotech Dental’s strategy is based on continuous innovation in both software and digital manufacturing processes.
This technological culture has enabled the group to build an offer of high quality products at affordable prices, 100% “Made in France”, in their manufacturing centers in the Arve Valley (Rhône-Alpes) and Salon-de-Provence, where its head office is also located.
The funds in the Artemid range are managed by the asset management company CAPZA as well as a third party portfolio management company and advised by Artemid SAS, a joint subsidiary of CAPZA and Amiral Gestion. Artemid SAS is a financial investment advisor (conseiller en investissement financier – CIF) registered at the ORIAS under the number 14003497 since 5/28/2014.
-
16Feb’ 2026CAPZA announces the successful first closing of the European Mid-Market private debt fundCAPZA Private Debt 7 raised nearly €1.4bn.Read more -
2Feb’ 2026Antoine Druais appointed
Co-Head of the Flex Equity Mid-Market TeamCAPZA announces the appointment of Antoine Druais as a Co-Head of the Flex Equity Mid-Market TeamRead more -
29Jan’ 2026CAPZA supports Concerto's growth strategyCAPZA acquires a minority stake in Concerto.Read more -
28Jan’ 2026CAPZA Partners with UUDSCAPZA Partners with UUDS, a Leading Player in Premium Aircraft Cabin Interior SolutionsRead more